A carregar...

Safety, stability and pharmacokinetic properties of (super)Factor Va, a novel engineered coagulation factor V for treatment of severe bleeding

PURPOSE: Activated (super)Factor V ((super)FVa) is a novel engineered FV with excellent prohemostatic efficacy. (Super)FVa has three APC cleavage site mutations and an interdomain disulfide bond. Stability, pharmacokinetics, and immunogenic and thrombogenic potential are reported here. METHODS: Stab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharm Res
Main Authors: Gale, Andrew J., Bhat, Vikas, Pellequer, Jean-Luc, Griffin, John H., Mosnier, Laurent, von Drygalski, Annette
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4854778/
https://ncbi.nlm.nih.gov/pubmed/26960296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-016-1895-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!